Previous 10 | Next 10 |
2023-10-31 17:21:48 ET More on Novavax Moderna Vs. Novavax: Neither Offering Short-Term Value As Fall Vaccine Season Begins Stocks To Watch: Tesla, Netflix, And AT&T Headline Big Week Of Earnings Novavax's COVID-19 Investment Thesis Is Old News Novavax wi...
Novavax's Updated COVID-19 Vaccine Now Approved in the EU PR Newswire Novavax's updated COVID-19 vaccine is the only updated protein-based non-mRNA COVID-19 vaccine available in the European Union for individuals aged 12 and older Novavax is working closely with EU m...
Novavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU PR Newswire Pending a European Commission decision, Novavax's vaccine will be the only updated protein-based non-mRNA COVID-19 vaccine available in Europe for individuals a...
2023-10-31 07:19:25 ET More on Pfizer Pfizer: Ignore The Noise And Buy This Deep Value Seagen's Acquisition: EU Approval And Potential Upside Pfizer: Huge Upside Potential And 5%+ Yield Pfizer reports mixed Q3 earnings; reaffirms FY23 outlook GSK is s...
2023-10-27 15:00:00 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week, or the Seeking Alpha earnings calendar ...
2023-10-27 09:11:19 ET Summary Moderna, the world leader in mRNA vaccines, has seen its revenues collapse due to waning Covid severity and global immunity. Its stock price is close to a three-year low. However, the company pipeline is rich and has new treatments (Merck-Moderna Key...
2023-10-18 08:37:31 ET More on Novavax Moderna Vs. Novavax: Neither Offering Short-Term Value As Fall Vaccine Season Begins Stocks To Watch: Tesla, Netflix, And AT&T Headline Big Week Of Earnings Novavax's COVID-19 Investment Thesis Is Old News Novavax's ...
Novavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid™ ▼ in United Kingdom PR Newswire Full authorization of prototype enables rapid authorization of updated Novavax COVID-19 vaccines in future GAITHERSBURG, Md....
Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore PR Newswire GAITHERSBURG, Md. , Oct. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M !...
2023-10-17 12:57:59 ET Summary Pfizer's downgrade in revenue guidance for its COVID drug products raises concerns about the revenue outlook for Moderna and Novavax. Moderna's updated Spikevax COVID vaccine has been approved for individuals 12 years and older, while Novavax's prote...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...